January 8, 2010 – Transradial angiography leads to reduced patient complications, faster recovery time and decreased hospital costs, according to cardiologists at the University of Illinois at Chicago (UIC) and Jesse Brown VA medical centers. They are among the first in the Chicago area to offer the new approach to heart angiograms and clearing blocked arteries.
January 8, 2010 – Japanese regulatory officials this week cleared the XIENCE V Everolimus-Eluting Coronary Stent. Abbott said it plans to launch sales in Japan in the coming weeks, immediately following final reimbursement authorization.
January 7, 2010 – Doctors with Virginia Interventional and Vascular Associates (VIVA) report success in treating acute deep vein thrombosis (DVT) with a procedure called isolated pharmacomechanical thrombolysis (IPMT). The treatment has been used for the past two years to destroy clots much faster than traditional therapies.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 7, 2010 – Anti-platelet treat with Effient (prasugrel) compared with Plavix (clopidogrel) was more cost effective, according to results from a health economic substudy of the TRITON-TIMI 38 trial. The trial looked at the drug treatments in patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI).
January 6, 2010 - The image quality of multidetector computed tomography (MDCT) scans used for the noninvasive detection of coronary artery disease can be significantly affected by patient characteristics, such as ethnicity, body mass index (BMI), and heart rate.
January 6, 2010 – European CE mark clearance was granted this week for the Volcano OCT (optical coherence tomography) imaging system and catheter. Volcano said its OCT system will be commercially available in Europe in early 2011.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 6, 2010 – Two validation studies for a wireless, hand-held, patient-activated device that records and transmits reconstructed 12-lead ECGs confirmed the product's ability to accurately provide remote patient monitoring.
January 6, 2010 – The FDA, in collaboration with major implantable pacemaker and implantable cardioverter-defibrillator (ICD) manufacturers, demonstrated the effects of emissions from radio frequency identification (RFID) readers on common implantable cardiac devices.
January 5, 2010 – In vivo and in vitro data released yesterday shows a new bioresorbable stent platform allows for complete endothelialization with little inflammation after one month.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 5, 2010 – St. Paul’s Hospital in Vancouver, Canada recently was the first to use the Embrella Embolic Deflector cerebral protection system. The device uses a porous membrane to deflect emboli away from the carotid arteries. It is inserted through the right radial or right brachial artery, away from the femoral artery, which is the typical access site for procedures.
January 4, 2010 – The first patient was enrolled the TAXUS Liberte arm of the Dual Anti-Platelet Therapy (DAPT) Study, evaluating the TAXUS Liberté stent in combination with a dual anti-platelet therapy drug that includes aspirin and Effient.
January 4, 2010 – The new design of the D-Stat Rad-Band incorporates a quick-release feature and a larger release tab, making it easier to detach the translucent comfort pad without disrupting clot integrity.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
January 4, 2010 – The FDA's permission is sought to allow a safety and feasibility trial for the PHOENIX System, which allows tissue stimulation and injections of biologic or pharmacologic agents to the myocardium. The system is designed to treat patients with refractory angina.
December 31, 2009 – A new micro-introducer kit launched this week features a stiffened introducer option. The AngioDynamics micro-introducers allow physicians to perform percutaneous introduction of a guide wire or catheter into the peripheral vasculature using a 21-gauge needle.
December 30, 2009 – Medical device company Emerging Healthcare Solutions LLC (EHS) entered into an agreement to distribute ThromboVision’s T-Guide, a new diagnostic test to assess patient response to clopidogrel. The option agreement gives the companies a mutual due diligence review period prior to completing an investment and profit sharing agreement.